Immitra Bio is a pioneer in next-generation gene therapy platforms.
Immitra Bio has raised $2.8M in total funding. The most recent round was Pre-Seed. The last funding was announced in July 2026.
Immitra Bio's investors include Venture Kick, Zürcher Kantonal Bank, Kickfund, FONGIT, another.vc.
Immitra Bio is headquartered in Schlieren, Switzerland.
Immitra Bio is a pioneer in next-generation gene therapy platforms.
Immitra Bio is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Immitra Bio — Funding & Investors." VCBacked, July 21, 2026, https://www.vcbacked.co/company/immitra-bio. Accessed August 14, 2026.
VCBacked. (2026). Immitra Bio — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/immitra-bio
{{cite web |title=Immitra Bio — Funding & Investors |url=https://www.vcbacked.co/company/immitra-bio |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated